Observational Study of the Additive Effects of Pranlukast on Inflammatory Markers of Clinically Stable Asthma with Inhaled Corticosteroids and Long-Acting Beta 2 Agonists

By  

Respiration, Vol. 76, Iss. 4, 2008-08 ,pp. : 398-402

Karger

Access to resources Recommend Favorite

Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting β2-agonists: addition of montelukast in an open-label pilot study

By Dupont Lieven   Potvin Emmanuel   Korn Dana   Lachman Albert   Dramaix Michèle   Gusman Julie   Peché Rudi  

Current Medical Research and Opinion, Vol. 21, Iss. 6, 2005-06 ,pp. : 863-870

Informa Healthcare

Access to resources Recommend Favorite

Inhalation devices for long-acting β₂-agonists: efficiency and ease of use of dry powder formoterol inhalers for use by patients with asthma and COPD

By Molimard Mathieu   Till Denise   Stenglein Stephan   Singh Dilraj   Krummen Markus  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2405-2413

Informa Healthcare

Access to resources Recommend Favorite

Risk of all-cause hospitalization in COPD patients initiating long-acting or short-acting beta agonist therapy

By Bollu Vamsi  

Journal of Medical Economics, Vol. 16, Iss. 8, 2013-08 ,pp. : 1082-1088

Informa Healthcare

Access to resources Recommend Favorite

Corticosteroids plus Long-Acting Beta₂-Agonists Prevent Double-Stranded RNA-Induced Upregulation of B7-H1 on Airway Epithelium

By  

International Archives of Allergy and Immunology, Vol. 160, Iss. 1, 2012-08 ,pp. : 27-36

Karger

Access to resources Recommend Favorite